Background: Worldwide, hepatocellular carcinoma (HCC) is more prevalent in
men than in women, suggesting that sex hormones and/or X-chromosome-linked
genes may be involved in hepatocarcinogenesis. We investigated the associat
ion of a trinucleotide (CAG) repeat in the androgen receptor (AR) gene (loc
ated on the X chromosome) termed "AR-CAG repeats," levels of plasma testost
erone, and the risk of HCC in Taiwanese men. Chronic hepatitis B virus (HBV
) infection, which is associated with risk of HCC, is hyperendemic in Taiwa
n, Methods: We compared the number of AR-CAG repeats in 285 HBV carriers wi
th HCC and in 349 HBV carriers without HCC. We also conducted a nested case
-control study on participants in a cohort study. Blood was collected prosp
ectively from 110 case patients and 239 control subjects and was used to de
termine the number of AR-CAG repeats and plasma testosterone level. All sta
tistical tests were two-sided. Results: The overall odds ratio (OR) for HCC
was 1.72 (95% confidence interval [CI] = 1.03-2.89) for HBV carriers with
20 or fewer AR-CAG repeats compared with those with more than 24 repeats. T
his association was observed only in patients with late-onset HCC (OR = 2.3
7; 95% CI = 1.28-4.38). In the nested case-control study, HBV carriers in t
he highest tertile of testosterone levels had a statistically significantly
increased risk of HCC (OR = 2.06; 95% CI = 1.14-3.70) compared with those
in the lowest tertile. Elevated testosterone was more strongly associated w
ith early-onset (OR = 4.67; 95% CI = 1.41-15.38) than late-onset disease. H
BV carriers with 20 or fewer AR-CAG repeats and higher testosterone levels
had a four-fold increase in HCC risk compared with those with more than 24
repeats and testosterone levels in the lowest tertile. Conclusions: Higher
levels of androgen signaling, reflected by higher testosterone levels and 2
0 or fewer AR-CAG repeats, may be associated with an increased risk of HBV-
related HCC in men.